# OnCo record in-vivo-gene-editing-cancer (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/in-vivo-gene-editing-cancer/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "in-vivo-gene-editing-cancer" ;
  schema:name "In vivo base and prime editing for cancer"@en ;
  schema:description "In vivo base and prime editing would rewrite a cancer's DNA letter by letter inside the body. It works in the liver for inherited disease; nobody has yet corrected a cancer this way in a person."@en ;
  schema:url <https://onco.cc/technologies/in-vivo-gene-editing-cancer/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?term=base%20editing> ;
  onco:status "concept" ;
  onco:tag "frontier", "radical" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/crispr-screens/>, <https://onco.cc/technologies/in-vivo-car-t/>, <https://onco.cc/technologies/programmable-dna-targeting-therapeutics/> ;
  onco:targets <https://onco.cc/targets/tp53/>, <https://onco.cc/targets/kras/> .
